Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma

Abstract Background The optimal time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery for esophageal squamous cell carcinoma remains unknown. This research aims to assess the impact of time interval on pathological response and survival prognosis. Methods Esophageal squa...

Full description

Saved in:
Bibliographic Details
Main Authors: Guanzhi Ye, Gaojian Pan, Xiaolei Zhu, Hongming Liu, Ning Li, Guojun Geng, Jie Jiang
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-025-03802-5
Tags: Add Tag
No Tags, Be the first to tag this record!